Senators push to reduce animal testing in $5.5B research field

(The Center Square) – A bipartisan group of U.S. senators has reintroduced legislation to push the Food and Drug Administration to adopt modern alternatives to animal testing.

The bill would require the FDA to speed up its approval of new testing methods that don’t involve animals, such as cell-based research, computer models, and lab-grown organ tissues. These methods are said to be more reliable, cost-effective, and humane.

The National Institute of Health, the primary U.S. government agency responsible for medical and health research, spends approximately $5.5 billion annually on taxpayer-funded animal testing, according to documents.

U.S. Sen. Corey Booker, D-N.J., the bill’s leading sponsor, said, “We cannot allow the FDA to continue to delay implementing this critical law. If passed, this bipartisan legislation will require the FDA to finally update its regulations and will pave the way for more scientifically reliable and humane methods of drug development.”

Between 90% and 95% of drugs that pass animal testing fail in human trials, which can take up to 15 years and cost between $1 billion and $6 billion, according to a news release from the Animal Legal Defense Fund.

- Advertisement -

The legislation also builds on similar laws passed, known as the FDA Modernized Act 2.0, which allows drug companies to use alternatives to animal testing. However, lawmakers say that the FDA has been slow to implement the new changes, resulting in the push for clearer guidelines to make the alternatives more accepted.

“For too long, bureaucratic inertia has delayed the implementation of these changes, which are vital to saving lives, reducing costs, and bringing life-saving treatments to patients more efficiently. This legislation sends a clear message: Americans deserve a regulatory system that embraces innovation, not one stuck in the past,” U.S. Sen. Rand Paul, R-Ky said in a statement.

The bill has garnered support from Democrats and Republicans, with co-sponsors such as Eric Schmitt, R-Mo., Paul, Angus King, I-Maine, John Kennedy, R-La., Sheldon Whitehouse, D-R.I., Ben Ray Luján, D-N.M., Roger Marshall, R-Kansas, and Richard Blumenthal, D-Conn.

“It is essential that FDA be proactive in using the most predictive scientific methods in its decision-making. Human-centric techniques such as organs-on-a-chip and organoids are developing rapidly and have the potential to improve, and even accelerate, bringing safe and effective products to the market,” said Paul A. Locke, JD, DrPH, professor, Johns Hopkins Bloomberg School of Public Health.

He continued, “This legislation will focus FDA’s attention where it needs to be – improving regulations that will lead to better treatments, more cures.”

Hot this week

African and Caribbean Nations Call for Reparations for Slave Trade, Propose Global Fund

Nations across Africa and the Caribbean, deeply impacted by...

Sports betting expert offers advice on paying taxes for gambling winnings

(The Center Square) – Tax season is underway, and...

Health care company agrees to pay $22.5 million to settle claims of over billing

A health care company agreed to pay nearly $22.5...

Entertainment district benefits don’t outweigh the cost, economists say

(The Center Square) — Weeks later, after more details...

Business association ‘disappointed’ by WA L&I’s proposed workers comp rate hike

(The Center Square) – The Association of Washington Business...

Report questions utility of Trump’s steel tariffs

(The Center Square) – President Donald Trump’s unilateral tariffs...

Fuel prices absorb tariff talk spike, volatility

(The Center Square) – Fuel prices in North Carolina...

Minimum wage deal pending, set to increase to $12.48 Friday

(The Center Square) – A last-minute legislative compromise on...

Annual statewide audit reveals billions in questioned costs and mismanagement

(The Center Square) − The Louisiana Legislative Auditor’s latest...

Illinoisans can nominate and choose coolest products made in the state

(The Center Square) – Nominations are now being accepted...

Report: Mental health funding skips high-need areas

(The Center Square) - California’s mental health funding skips...

King Soopers strike continues as company calls for an agreement

(The Center Square) – The workers strike at King...

Sandhills transformer facility expansion aided by performance grant

(The Center Square) – North Carolina’s Commerce Department is...

More like this
Related

Report questions utility of Trump’s steel tariffs

(The Center Square) – President Donald Trump’s unilateral tariffs...

Fuel prices absorb tariff talk spike, volatility

(The Center Square) – Fuel prices in North Carolina...

Minimum wage deal pending, set to increase to $12.48 Friday

(The Center Square) – A last-minute legislative compromise on...

Annual statewide audit reveals billions in questioned costs and mismanagement

(The Center Square) − The Louisiana Legislative Auditor’s latest...